Jefferies Financial Group’s AstraZeneca AZN Stock Holding History

Jefferies Financial Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.9M	Buy	186,676 +171,888	+1,162%	+$32.3M	0.23%	88
2026 Q1	$2.88M	Buy	14,788 +10,800	+271%	+$2.08M	0.02%	491
2025 Q4	$733K	Buy	+3,988	New	+$699K	﹤0.01%	1215
2025 Q2	–	Sell	-3,148	Closed	-$463K	–	1298
2025 Q1	$463K	Buy	+3,148	New	+$455K	﹤0.01%	1066
2024 Q4	–	Sell	-1,304	Closed	-$203K	–	1593
2024 Q3	$203K	Buy	+1,304	New	+$210K	﹤0.01%	1224
2024 Q1	–	Sell	-1,850	Closed	-$249K	–	1611
2023 Q4	$249K	Sell	1,850 -4,135	-69%	-$538K	﹤0.01%	1427
2023 Q3	$811K	Sell	5,985 -14,064	-70%	-$1.92M	0.01%	897
2023 Q2	$2.87M	Buy	20,049 +2,083	+12%	+$306K	0.03%	536
2023 Q1	$2.49M	Sell	17,966 -195	-1%	-$26.2K	0.02%	586
2022 Q4	$2.46M	Buy	+18,161	New	+$2.28M	0.02%	588

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jefferies Financial Group's AZN Position: Q2 2026 in Review

Jefferies Financial Group increased its AstraZeneca (AZN) stake by 1,162% in Q2 2026, buying an estimated $32.3M and bringing the position to 186,676 shares worth $34.9M. The position accounts for 0.23% of the portfolio, ranked #88.

Jefferies Financial Group first reported a position in AZN in Q4 2022 and has held it in 10 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Jefferies Financial Group held 186,676 shares of AstraZeneca worth $34.9M as of Q2 2026.
Jefferies Financial Group bought 171,888 AstraZeneca shares in Q2 2026, an estimated $32.3M.
AstraZeneca made up 0.23% of Jefferies Financial Group's portfolio in Q2 2026, its #88 holding.
Jefferies Financial Group first reported a position in AstraZeneca in Q4 2022 and has held it in 10 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.